These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8195408)

  • 1. Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.
    Doellgast GJ; Triscott MX; Beard GA; Bottoms JD
    J Clin Microbiol; 1994 Mar; 32(3):851-3. PubMed ID: 8195408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies.
    Doellgast GJ; Beard GA; Bottoms JD; Cheng T; Roh BH; Roman MG; Hall PA; Triscott MX
    J Clin Microbiol; 1994 Jan; 32(1):105-11. PubMed ID: 8126163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay.
    Doellgast GJ; Triscott MX; Beard GA; Bottoms JD; Cheng T; Roh BH; Roman MG; Hall PA; Brown JE
    J Clin Microbiol; 1993 Sep; 31(9):2402-9. PubMed ID: 8408563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B, and E: use of hapten-labeled-antibody elution to isolate specific complexes.
    Doellgast GJ; Brown JE; Koufman JA; Hatheway CL
    J Clin Microbiol; 1997 Mar; 35(3):578-83. PubMed ID: 9041392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.
    Wictome M; Newton K; Jameson K; Hallis B; Dunnigan P; Mackay E; Clarke S; Taylor R; Gaze J; Foster K; Shone C
    Appl Environ Microbiol; 1999 Sep; 65(9):3787-92. PubMed ID: 10473376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F.
    Poli MA; Rivera VR; Neal D
    Toxicon; 2002 Jun; 40(6):797-802. PubMed ID: 12175617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody to type F Clostridium botulinum toxin.
    Ferreira JL; Hamdy MK; McCay SG; Zapatka FA
    Appl Environ Microbiol; 1990 Mar; 56(3):808-11. PubMed ID: 2180373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity.
    Sayadmanesh A; Ebrahimi F; Hajizade A; Rostamian M; Keshavarz H
    Iran Biomed J; 2013; 17(4):165-70. PubMed ID: 23999711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of mucosal IgA in the equine small intestine: specific IgA in cases of acute grass sickness and controls.
    Nunn FG; Pirie RS; McGorum B; Wernery U; Poxton IR
    Equine Vet J; 2007 Sep; 39(5):457-60. PubMed ID: 17910272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
    Shone C; Wilton-Smith P; Appleton N; Hambleton P; Modi N; Gatley S; Melling J
    Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
    Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
    Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Clostridium botulinum toxin A using a fiber optic-based biosensor.
    Ogert RA; Brown JE; Singh BR; Shriver-Lake LC; Ligler FS
    Anal Biochem; 1992 Sep; 205(2):306-12. PubMed ID: 1443578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)?
    Hunter LC; Poxton IR
    Equine Vet J; 2001 Nov; 33(6):547-53. PubMed ID: 11720025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies to type A, B, E and F botulinum neurotoxins].
    Abbasova SG; Ruddenko NV; Gorokhovatskiĭ AIu; Kapralova MV; Vinogradova ID; Vertiev IuV; Nesmeianov VA; Grishin EV
    Bioorg Khim; 2011; 37(3):344-53. PubMed ID: 21899049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.